Sign in

CIK 0001410098 · Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
  1. ARS Other Annual Report to Security Holders
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. 8-K Event Auditor change
  5. 8-K Event Results of operations
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 4 Option exercise Director acquired 20,000 shares (option exercise)
  8. 4 Option exercise Chief Executive Officer acquired 59,170 shares (option exercise)
  9. 10-K Report Annual Report
  10. 8-K Event Results of operations
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 23,977 shares (to pay taxes)
  13. 4 Grant or award Director acquired 25,000 shares (grant or award)
  14. 4 Grant or award Director acquired 25,000 shares (grant or award)
  15. 4 Grant or award Director acquired 25,000 shares (grant or award)
  16. 4 Grant or award Director acquired 25,000 shares (grant or award)
  17. 4 Grant or award Director acquired 25,000 shares (grant or award)
  18. 4 Grant or award Director acquired 25,000 shares (grant or award)
  19. 4 Shares withheld for taxes Chief Financial Officer gave up 6,515 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 17,829 shares (to pay taxes)

Page 7 of 58 · 1,142 filings